Russell Investments Group’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Buy
976
+711
+268% +$14.7K ﹤0.01% 3789
2026
Q1
$4.55K Hold
265
﹤0.01% 3908
2025
Q4
$6.19K Buy
265
+13
+5% +$336 ﹤0.01% 3873
2025
Q3
$8K Buy
+252
New +$7.61K ﹤0.01% 3829
2024
Q1
Sell
-85
Closed -$3.49K 3362
2023
Q4
$3.49K Sell
85
-61
-42% -$1.96K ﹤0.01% 2949
2023
Q3
$4.54K Buy
+146
New +$5.66K ﹤0.01% 3159

Other funds holding SMTI

Russell Investments Group's SMTI Position: Q2 2026 in Review

Russell Investments Group increased its Sanara MedTech (SMTI) stake by 268% in Q2 2026, buying an estimated $14.7K and bringing the position to 976 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3789.

Russell Investments Group first reported a position in SMTI in Q3 2023 and has held it in 6 quarters since. 31 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Russell Investments Group held 976 shares of Sanara MedTech worth $23K as of Q2 2026.
  • Russell Investments Group bought 711 Sanara MedTech shares in Q2 2026, an estimated $14.7K.
  • Sanara MedTech made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3789 holding.
  • Russell Investments Group first reported a position in Sanara MedTech in Q3 2023 and has held it in 6 quarters since.
  • 31 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.